GSEA enrichment analysis (Figure 6C) revealed there was no considerable enrichment of pathways in the high‐risk cohort, but demonstrated a considerable enrichment of immune‐associated and cancer‐associated pathways in the low‐risk cohort including the Fc gamma R‐mediated phagocytosis, Fc epsilon RI signaling pathway, B cell receptor signaling pathway, primary immunodeficiency, T‐ cell receptor signaling pathway, and VEGF signaling pathway. The gene discussed is VEGFA; the disease is cancer.